Reversible posterior leukoencephalopathy syndrome (RPLS) in a heart transplant recipient treated by substitution of cyclosporine a with tacrolimus

Internal Medicine

Volumn 49, Issue 11, 2010, Pages 1013-1016

  Oda, Noboru ^a   Kato, Tomoko S ^a   Hanatani, Akihisa ^a   Niwaya, Kazuo ^a   Nakatani, Takeshi ^a   Ishibashi Ueda, Hatsue ^a   Kitamura, Soichiro ^a   Hashimura, Kazuhiko ^a   Kitakaze, Masafumi ^a   Komamura, Kazuo ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

Calcineurin inhibitors; Complications; Heart transplant; Immunosuppression; Reversible posterior leukoencephalopathy syndrome

Indexed keywords

CYCLOSPORIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS;

ACUTE GRAFT REJECTION; ADULT; ANTICOAGULATION; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONGESTIVE CARDIOMYOPATHY; DIASTOLIC BLOOD PRESSURE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HEART TRANSPLANTATION; HUMAN; POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME; SYSTOLIC BLOOD PRESSURE; TRANSIENT ISCHEMIC ATTACK; TREATMENT RESPONSE;

CYCLOSPORINE; FEMALE; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; MIDDLE AGED; POSTERIOR LEUKOENCEPHALOPATHY SYNDROME; TACROLIMUS; TRANSPLANTATION; TREATMENT OUTCOME;

EID: 77953337860     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.49.3012     Document Type: Article

References (15)

1. Zivkovic S. Neuroimaging and neurologic complications after organ transplantation. J Neuroimaging 17: 110-123, 2007.
2. Kaczmarek I, Schmauss D, Sodian R, et al. Late-onset tacrolimusassociated cerebellar atrophia in a heart transplant recipient. J Heart Lung Transplant 26: 89-92, 2007.
3. Fisher NC, Ruban E, Carey M, Heafield MT, West RJ, Adams DH. Late-onset fatal acute leucoencephalopathy in liver transplant recipient. Lancet 349: 1884-1885, 1997.
4. Muñoz R, Espinoza M, Espinoza O, Andrade A, Bravo E, González F. Cyclosporine-associated leukoencephalopathy in organ transplant recipients: experience of three clinical cases. Transplant Proc 38: 921-923, 2006.
5. Lee VH, Wijdicks EF, Manno EM, Rabinstein AA. Clinical spectrum of reversible posterior leukoencephalopathy syndrome. Arch Neurol 65: 205-210, 2008.
6. Kwon S, Koo J, Lee S. Clinical spectrum of reversible posterior leukoencephalopathy syndrome. Pediatr Neurol 24: 361-364, 2001.
7. Akutsu N, Iwashita C, Maruyama M, et al. Two cases of calcineurin inhibitor-associated reversible posterior leukoencephalopathy syndrome in renal transplant recipients. Transplant Proc 40: 2416-2418, 2008.
8. Hinchey J, Chaves C, Appignani B, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 334: 494-500, 1996
9. Hauser RA, Lacey DM, Knight MR. Hypertensive encephalopathy: magnetic resonance imaging demonstration of reversible cortical and white matter lesions. Arch Neurol 45: 1078-1083, 1998.
10. Bechstein WO. Neurotoxicity of calcineurin inhibitors: impact and clinical management. Transpl Int 13: 313-326, 2000.
11. Kubo SH, Naftel DC, Mills RM Jr, et al. Risk factors for late recurrent rejection after heart transplantation: a multiinstitutional, multivariable analysis. Cardiac Transplant Research Database Group. J Heart Lung Transplant 14: 409-418, 1995.
12. Mak A, Chan BP, Yeh IB, et al. Neuropsychiatric lupus and reversible posterior leukoencephalopathy syndrome: a challenging clinical dilemma. Rheumatology 47: 256-262, 2008.
13. Kaczmarek I, Groetzner J, Meiser B, et al. Impairment of the blood-brain barrier can result in tacrolimus-induced reversible leucoencephalopathy following heart transplantation. Clin Transplant 17: 469-472, 2003.
14. Singh N, Bonham A, Fukui M. Immunosuppressive-associated leukoencephalopathy in organ transplant recipients. Transplantation 69: 467-472, 2000.
15. Dzudie A, Boissonnat P, Roussoulieres A, et al. Cyclosporinerelated posterior reversible encephalopathy syndrome after heart transplantation: should we withdraw or reduce cyclosporine?: case reports. Transplant Proc 41: 716-720, 2009.